TP53 and neoplasm: Although we acquire a negative consequence of SERPINE1 (also known as plasminogen activator inhibitor-1, PAI-1) in validation analysis; interestingly, it has been widely studied and is well known for participating p53 signaling pathway and playing a crucial role in tumor progression and angiogenesis [54, 55].